395 related articles for article (PubMed ID: 12925853)
1. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.
Wald D; Qin J; Zhao Z; Qian Y; Naramura M; Tian L; Towne J; Sims JE; Stark GR; Li X
Nat Immunol; 2003 Sep; 4(9):920-7. PubMed ID: 12925853
[TBL] [Abstract][Full Text] [Related]
2. TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.
Garlanda C; Anders HJ; Mantovani A
Trends Immunol; 2009 Sep; 30(9):439-46. PubMed ID: 19699681
[TBL] [Abstract][Full Text] [Related]
3. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR.
Mantovani A; Locati M; Polentarutti N; Vecchi A; Garlanda C
J Leukoc Biol; 2004 May; 75(5):738-42. PubMed ID: 14673019
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta.
Yamamoto M; Yamazaki S; Uematsu S; Sato S; Hemmi H; Hoshino K; Kaisho T; Kuwata H; Takeuchi O; Takeshige K; Saitoh T; Yamaoka S; Yamamoto N; Yamamoto S; Muta T; Takeda K; Akira S
Nature; 2004 Jul; 430(6996):218-22. PubMed ID: 15241416
[TBL] [Abstract][Full Text] [Related]
5. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis.
Xiao H; Gulen MF; Qin J; Yao J; Bulek K; Kish D; Altuntas CZ; Wald D; Ma C; Zhou H; Tuohy VK; Fairchild RL; de la Motte C; Cua D; Vallance BA; Li X
Immunity; 2007 Apr; 26(4):461-75. PubMed ID: 17398123
[TBL] [Abstract][Full Text] [Related]
6. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense.
Dunne A; O'Neill LA
Sci STKE; 2003 Feb; 2003(171):re3. PubMed ID: 12606705
[TBL] [Abstract][Full Text] [Related]
8. The interleukin-1 receptor family.
Boraschi D; Tagliabue A
Vitam Horm; 2006; 74():229-54. PubMed ID: 17027517
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach.
Gong J; Wei T; Stark RW; Jamitzky F; Heckl WM; Anders HJ; Lech M; Rössle SC
J Struct Biol; 2010 Mar; 169(3):323-30. PubMed ID: 20025973
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
[TBL] [Abstract][Full Text] [Related]
11. The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts.
Noris M; Cassis P; Azzollini N; Cavinato R; Cugini D; Casiraghi F; Aiello S; Solini S; Cassis L; Mister M; Todeschini M; Abbate M; Benigni A; Trionfini P; Tomasoni S; Mele C; Garlanda C; Polentarutti N; Mantovani A; Remuzzi G
J Immunol; 2009 Oct; 183(7):4249-60. PubMed ID: 19734209
[TBL] [Abstract][Full Text] [Related]
12. SIGIRR puts the brakes on Toll-like receptors.
O'Neill LA
Nat Immunol; 2003 Sep; 4(9):823-4. PubMed ID: 12942080
[No Abstract] [Full Text] [Related]
13. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells.
Weighardt H; Jusek G; Mages J; Lang R; Hoebe K; Beutler B; Holzmann B
Eur J Immunol; 2004 Feb; 34(2):558-64. PubMed ID: 14768061
[TBL] [Abstract][Full Text] [Related]
14. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
15. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
Schmitz F; Mages J; Heit A; Lang R; Wagner H
Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
[TBL] [Abstract][Full Text] [Related]
17. Primary immunodeficiency to pneumococcal infection due to a defect in Toll-like receptor signaling.
Currie AJ; Davidson DJ; Reid GS; Bharya S; MacDonald KL; Devon RS; Speert DP
J Pediatr; 2004 Apr; 144(4):512-8. PubMed ID: 15069402
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor-mediated responses of primary intestinal epithelial cells during the development of colitis.
Singh JC; Cruickshank SM; Newton DJ; Wakenshaw L; Graham A; Lan J; Lodge JP; Felsburg PJ; Carding SR
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G514-24. PubMed ID: 15499080
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily.
Thomassen E; Renshaw BR; Sims JE
Cytokine; 1999 Jun; 11(6):389-99. PubMed ID: 10346978
[TBL] [Abstract][Full Text] [Related]
20. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
Seki E; Tsutsui H; Iimuro Y; Naka T; Son G; Akira S; Kishimoto T; Nakanishi K; Fujimoto J
Hepatology; 2005 Mar; 41(3):443-50. PubMed ID: 15723296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
